acquired
Stage
1
Investors
About
Aelix Therapeutics is a biotechnology company based in Barcelona, Spain, developing therapeutic vaccines using the HTI immunogen to target HIV viral regions and support HIV cure strategies.
Explore Aelix Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.